Lead · Industry
FDA Approves RHA Redensity Eye for Undereye Hollowing
FDA Approves RHA Redensity Eye for Infraorbital Hollows
On August 27, 2026, the FDA approved RHA Redensity Eye for correcting moderate to severe infraorbital volume loss and hollowing in adults aged 22 years or older, giving injectors a specialized hyaluronic acid filler specifically engineered to handle the delicate and highly dynamic undereye area. This expansion of the Teoxane RHA Collection addresses a historically tricky zone where traditional, stiffer fillers often look unnatural during facial movement or cause delayed swelling.
